Literature DB >> 21736901

Differential expression of proteins in antimony-susceptible and -resistant isolates of Leishmania donovani.

Neha Biyani1, Alok Kumar Singh, Swati Mandal, Bhavna Chawla, Rentala Madhubala.   

Abstract

Visceral Leishmaniasis (VL) is a parasitic disease caused by the protozoan parasite Leishmania donovani. Resistance to pentavalent antimonials (SbV), the mainstay therapy for leishmaniasis is now a major concern, due to emergence of drug resistance. Hence, understanding the underlying mechanism of resistance to antimonials is required. Here we used quantitative mass spectrometery to identify global proteome differences between antimony-susceptible/-resistant isolates. We detected modification of expression of proteins involved in the key metabolic pathways. Comparative proteomic analysis indicated increase in glycolysis in the antimony-resistant isolates. Elevated expression of stress related proteins implicated in oxidative stress was observed in the resistant parasites. Most importantly, we observed upregulation of proteins that may have a role in intracellular survival of the parasite in the resistant isolates. The identified parasite proteins could serve as surrogate markers for resistance or susceptibility and would also help in understanding the underlying mechanism of resistance to antimonials.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21736901     DOI: 10.1016/j.molbiopara.2011.06.004

Source DB:  PubMed          Journal:  Mol Biochem Parasitol        ISSN: 0166-6851            Impact factor:   1.759


  25 in total

Review 1.  Antimony transport mechanisms in resistant leishmania parasites.

Authors:  Frédéric Frézard; Rubens Monte-Neto; Priscila G Reis
Journal:  Biophys Rev       Date:  2014-01-25

Review 2.  Heat Shock Proteins as the Druggable Targets in Leishmaniasis: Promises and Perils.

Authors:  Pragya Prasanna; Arun Upadhyay
Journal:  Infect Immun       Date:  2021-01-19       Impact factor: 3.441

3.  Comparative analysis of the transcriptional responses of five Leishmania species to trivalent antimony.

Authors:  Julián Medina; Lissa Cruz-Saavedra; Luz Helena Patiño; Marina Muñoz; Juan David Ramírez
Journal:  Parasit Vectors       Date:  2021-08-21       Impact factor: 3.876

4.  Synergic effect of photodynamic therapy with methylene blue and surfactants in the inhibition of Candida albicans.

Authors:  Juliana Pereira Lyon; Rafael Reis Rezende; Mariana Penido Rabelo; Carlos José de Lima; Leonardo Marmo Moreira
Journal:  Mycopathologia       Date:  2012-11-28       Impact factor: 2.574

5.  Perspectives From Systems Biology to Improve Knowledge of Leishmania Drug Resistance.

Authors:  Elvira Cynthia Alves Horácio; Jéssica Hickson; Silvane Maria Fonseca Murta; Jeronimo Conceição Ruiz; Laila Alves Nahum
Journal:  Front Cell Infect Microbiol       Date:  2021-04-30       Impact factor: 5.293

6.  Over-Expression of Cysteine Leucine Rich Protein Is Related to SAG Resistance in Clinical Isolates of Leishmania donovani.

Authors:  Sanchita Das; Priyanka Shah; Rati Tandon; Narendra Kumar Yadav; Amogh A Sahasrabuddhe; Shyam Sundar; Mohammad Imran Siddiqi; Anuradha Dube
Journal:  PLoS Negl Trop Dis       Date:  2015-08-21

Review 7.  Molecular Chaperones of Leishmania: Central Players in Many Stress-Related and -Unrelated Physiological Processes.

Authors:  Jose M Requena; Ana M Montalvo; Jorge Fraga
Journal:  Biomed Res Int       Date:  2015-06-18       Impact factor: 3.411

Review 8.  Drug resistance in eukaryotic microorganisms.

Authors:  Alan H Fairlamb; Neil A R Gow; Keith R Matthews; Andrew P Waters
Journal:  Nat Microbiol       Date:  2016-06-24       Impact factor: 17.745

9.  Comparative mitochondrial proteomics of Leishmania tropica clinical isolates resistant and sensitive to meglumine antimoniate.

Authors:  Minoo Tasbihi; Faezeh Shekari; Homa Hajjaran; Majid Khanmohammadi; Ramtin Hadighi
Journal:  Parasitol Res       Date:  2020-04-30       Impact factor: 2.289

10.  Nelfinavir is effective in inhibiting the multiplication and aspartic peptidase activity of Leishmania species, including strains obtained from HIV-positive patients.

Authors:  Lívia O Santos; Bianca S Vitório; Marta H Branquinha; Conceição M Pedroso e Silva; André L S Santos; Claudia M d'Avila-Levy
Journal:  J Antimicrob Chemother       Date:  2012-10-28       Impact factor: 5.790

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.